Lentiviral gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lentiviral gene therapy, covering 2021-09-16 to 2021-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency [Phase 1, Phase 2]